| 000 | 01466 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513110858.0 | ||
| 264 | 0 | _c19970319 | |
| 008 | 199703s 0 0 eng d | ||
| 022 | _a1058-4838 | ||
| 024 | 7 |
_a10.1093/clinids/24.supplement_1.s139 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGoldmann, D A | |
| 245 | 0 | 0 |
_aControl of nosocomial antimicrobial-resistant bacteria: a strategic priority for hospitals worldwide. _h[electronic resource] |
| 260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cJan 1997 |
||
| 300 |
_aS139-45 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAlgorithms |
| 650 | 0 | 4 |
_aBacterial Infections _xdrug therapy |
| 650 | 0 | 4 | _aBoston |
| 650 | 0 | 4 |
_aCross Infection _xdrug therapy |
| 650 | 0 | 4 | _aDeveloped Countries |
| 650 | 0 | 4 | _aDeveloping Countries |
| 650 | 0 | 4 | _aDrug Resistance, Microbial |
| 650 | 0 | 4 |
_aEnterococcus _xdrug effects |
| 650 | 0 | 4 | _aGlobal Health |
| 650 | 0 | 4 |
_aGram-Positive Bacterial Infections _xdrug therapy |
| 650 | 0 | 4 | _aHospitals |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfection Control _xstandards |
| 650 | 0 | 4 | _aVancomycin |
| 700 | 1 | _aHuskins, W C | |
| 773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 24 Suppl 1 _gp. S139-45 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/clinids/24.supplement_1.s139 _zAvailable from publisher's website |
| 999 |
_c8986021 _d8986021 |
||